Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 33

1.

Genome study suggests new treatments for high-risk form of childhood leukemia.

McBride D.

ONS Connect. 2012 Nov;27(11):21. No abstract available.

PMID:
23316525
2.

Pharmacogenomics of childhood acute lymphoblastic leukemia.

Brenner TL, Pui CH, Evan WE.

Curr Opin Mol Ther. 2001 Dec;3(6):567-78. Review.

PMID:
11804271
3.

Pharmacogenomic effects on therapy for acute lymphoblastic leukemia in children.

Wall AM, Rubnitz JE.

Pharmacogenomics J. 2003;3(3):128-35. Review. No abstract available.

PMID:
12815362
4.

Pharmacogenetics of acute lymphoblastic leukemia treatment response.

Cunningham L, Aplenc R.

Expert Opin Pharmacother. 2007 Oct;8(15):2519-31. Review.

PMID:
17931087
5.

Pharmacogenetics influence treatment efficacy in childhood acute lymphoblastic leukemia.

Davidsen ML, Dalhoff K, Schmiegelow K.

J Pediatr Hematol Oncol. 2008 Nov;30(11):831-49. doi: 10.1097/MPH.0b013e3181868570. Review.

PMID:
18989161
6.

Biology and treatment of acute lymphoblastic leukemia.

Pieters R, Carroll WL.

Pediatr Clin North Am. 2008 Feb;55(1):1-20, ix. doi: 10.1016/j.pcl.2007.11.002. Review.

PMID:
18242313
7.

Pharmacogenetics in acute lymphoblastic leukemia.

Cheok MH, Pottier N, Kager L, Evans WE.

Semin Hematol. 2009 Jan;46(1):39-51. doi: 10.1053/j.seminhematol.2008.09.002. Review.

8.

Pharmacogenomics of acute lymphoid leukemia: new insights into treatment toxicity and efficacy.

Relling MV, Ramsey LB.

Hematology Am Soc Hematol Educ Program. 2013;2013:126-30. doi: 10.1182/asheducation-2013.1.126. Review.

PMID:
24319173
9.

Chemotherapy of acute myelocytic leukemia in children.

Lie SO, Jonmundsson GK, Mellander L, Siimes MA, Yssing M, Gustafsson G.

Ann N Y Acad Sci. 1997 Sep 17;824:84-90. Review. No abstract available.

PMID:
9382458
10.

[New therapeutic strategy for Philadelphia chromosome-positive acute lymphoblastic leukemia].

Usui N.

Rinsho Ketsueki. 2006 Apr;47(4):294-302. Review. Japanese. No abstract available.

PMID:
16715964
12.

Acute lymphoblastic leukaemia: a model for the pharmacogenomics of cancer therapy.

Cheok MH, Evans WE.

Nat Rev Cancer. 2006 Feb;6(2):117-29. Review. Erratum in: Nat Rev Cancer. 2006 Mar;6(3):249.

PMID:
16491071
13.

Role of pharmacogenomics and pharmacodynamics in the treatment of acute lymphoblastic leukaemia.

Pui CH, Relling MV, Evans WE.

Best Pract Res Clin Haematol. 2002 Dec;15(4):741-56. Review.

PMID:
12617874
14.

[Role of the laboratory scientist in the diagnosis and treatment of acute lymphoblastic leukemia in children].

Fournier M, Lambilliotte A.

Ann Biol Clin (Paris). 1998 May-Jun;56(3):343-7. Review. French. No abstract available.

15.

Genomic and pharmacogenetic studies of childhood acute lymphoblastic leukemia.

Pui CH.

Front Med. 2015 Mar;9(1):1-9. doi: 10.1007/s11684-015-0381-3. Epub 2014 Dec 15. Review.

PMID:
25511622
16.

Everything you always wanted to know about cellular drug resistance in childhood acute lymphoblastic leukemia.

Pieters R, Klumper E, Kaspers GJ, Veerman AJ.

Crit Rev Oncol Hematol. 1997 Jan;25(1):11-26. Review. No abstract available.

PMID:
9134309
17.

Therapy for childhood acute lymphoblastic leukemia.

Cassano WF, Eskenazi AE, Frantz CN.

Curr Opin Oncol. 1993 Jan;5(1):42-52. Review.

PMID:
8427893
18.

Pharmacogenomics of acute lymphoblastic leukemia.

Kager L, Evans WE.

Curr Opin Hematol. 2006 Jul;13(4):260-5. Review.

PMID:
16755223
19.

Adherence to oral chemotherapy in childhood acute lymphoblastic leukemia: an evolutionary concept analysis.

Landier W.

Oncol Nurs Forum. 2011 May;38(3):343-52. doi: 10.1188/11.ONF.343-352. Review.

20.

Treatment of acute lymphoblastic leukemia.

Hoelzer D.

Semin Hematol. 1994 Jan;31(1):1-15. Review. No abstract available.

PMID:
8122133

Supplemental Content

Support Center